Skip to main content

AncestryHealth

By Dave Muoio and Laura Lovett | 03:24 pm | January 20, 2021
Also: NIH moves forward with physIQ's COVID digital biomarkers; Tyto Care adds pulse oximeter.
By Dave Muoio | 04:15 pm | August 24, 2020
The consumer genomics company's existing offering, called AncestryHealth, sold clinician-ordered tests that were not cleared or approved by the FDA.            
By Laura Lovett | 02:43 pm | August 05, 2020
The deal is valued at roughly $4.7 billion. 
By Laura Lovett | 04:03 pm | August 03, 2020
The company said the product will give customers information about their genetic risk for certain diseases. 
By Jonah Comstock | 02:36 pm | May 20, 2019
The Israel-based company is offering 11 genetic risk tests, three polygenic risk tests and 15 carrier status reports.